Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Sosei Group Corporation
Sosei Group Corporation
Activities:
Ingredients
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Syngene opens novel biologics manufacturing facility
New facility includes 20KL of single use drug substance capacity, coupled with drug product filling capacity of up to one million vials per day
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
AstraZeneca to acquire Amolyt Pharma for up to $1.05 billion
The acquisition will facilitate the development of novel therapeutics for rare endocrine and related diseases
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Metrion and Sosei Heptares to explore structure-based drug design
Sosei Heptares will have exclusive global rights to all molecules identified
Research & Development
Sosei Heptares and PharmEnable enter drug discovery collaboration
The companies will jointly conduct and share the costs of the discovery and development program and will co-own any resulting products
Research & Development
Sosei Heptares announces €40 million Medicxi investment
Two asset-centric companies have been formed to develop Sosei’s novel therapies for neurological diseases funded by Medicxi
Recruitment
Sosei appoints Interim CFO
Media
Changes in executive management at Sosei
Manufacturing
Heptares founder Richard Henderson receives Nobel Prize in Chemistry 2017
Finance
Heptares Therapeutics enters agreement with Daichi Sankyo
The collaboration aims to discover and develop novel, small-molecules for the treatment of pain
Subscribe now